Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
10 stocks found for "Best British Dividend Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.18 | ±34.3% | 15.6 | 1.62% | |||
0.66 | ±23.0% | 8.5 | 7.73% | |||
0.45 | ±20.5% | 12.7 | 3.02% | |||
0.46 | ±18.0% | 32.0 | 2.08% | |||
0.71 | ±23.6% | 8.2 | 6.21% | |||
0.28 | ±21.2% | 10.3 | 6.19% | |||
0.35 | ±26.5% | 8.9 | 4.20% | |||
0.68 | ±20.5% | 43.6 | 11.87% | |||
0.48 | ±25.5% | 14.8 | 4.39% | |||
0.40 | ±17.8% | 17.5 | 3.04% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How do British stocks like UL and VOD typically perform in relation to dividend yields?
A: British stocks such as Unilever (UL) and Vodafone (VOD) are known for offering stable dividend yields, which can appeal to income-focused investors. Historically, their dividends have been reliable due to robust business operations, though investors should monitor financial health and market conditions.
Q: Are companies like HSBC and BTI considered growth or value stocks?
A: HSBC and British American Tobacco (BTI) are generally viewed as value stocks, offering dividends and stable returns rather than high growth. They often attract investors looking for steady income and defensive characteristics in economic downturns.
Q: What are the risks associated with investing in UK energy companies like SHEL?
A: Investing in UK energy companies such as Shell (SHEL) involves risks like fluctuating oil prices, regulatory changes, and transition pressures toward renewable energy. These factors can affect profitability and stock performance over time.
Q: How might economic cycles impact the performance of Rio Tinto (RIO)?
A: As a mining giant, Rio Tinto's (RIO) performance is sensitive to economic cycles, particularly commodity demand. During economic growth, demand for metals rises, boosting profitability, while downturns can decrease prices and revenues.
Q: What advantages do pharmaceutical companies like AstraZeneca (AZN) and GSK hold in the market?
A: AstraZeneca (AZN) and GlaxoSmithKline (GSK) possess competitive advantages due to their strong R&D capabilities, diverse product pipelines, and established global market presence, which often helps in maintaining revenue stability.
Q: Are consumer goods companies like JD Sports (JD) vulnerable to economic slowdowns?
A: JD Sports (JD) may be vulnerable to economic slowdowns as consumer spending tightens. Retail businesses often experience pressure on sales during recessions, which can impact profit margins and overall financial performance.
U.S. President Donald Trump has slammed an appeals court decision to temporarily block plans to develop a massive Arizona copper project. His comments come shortly after he met the chief executives of Rio Tinto and BHP at the White House.
Read morePresident Donald Trump demanded several pharmaceutical companies cut down their drug prices for American consumers Thursday, issuing a Sept. 29 deadline for the businesses to 'end the free ride of American innovation by European and other developed nations."
Read moreHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read more